AFT 'swimming with the tide against opioids' with Maxigesic, says CEO

AFT 'swimming with the tide against opioids' with Maxigesic, says CEO
Pattrick Smellie
By Pattrick Smellie Aug. 4 (BusinessDesk) - AFT Pharmaceuticals' combination ibuprofen/paracetamol painkiller Maxigesic is well-positioned to capture Australian and US market share as those markets move away from opioid painkillers such as codeine, managing director Hartley Atkinson told shareholders at the company's annual meeting in Auckland. In Australia, the company believes its sales of 26 million doses of Maxigesic in the last financial year should grow strongly as codeine-based painkillers are phased out as over-the-counter pain re...